A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.

Journal of the American College of Nutrition

Volumn 15, Issue 2, 1996, Pages 136-143

  Chasan Taber, Lisa ^a   Selhub, Jacob ^b   Rosenberg, Irwin H ^b   Malinow, M Rene ^c   Terry, Paul ^d   Tishler, Peter V ^e   Willett, Walter ^a,f   Hennekens, Charles H ^a,f   Stampfer, Meir J ^a,f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b TUFTS UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e BrocktonlWest Roxbury Veteran's Affairs Medical Center   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; PYRIDOXINE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; DISEASE ASSOCIATION; FOLIC ACID DEFICIENCY; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PROSPECTIVE STUDY; PYRIDOXINE DEFICIENCY; RISK ASSESSMENT; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; DIET; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; PYRIDOXAL PHOSPHATE; PYRIDOXINE; RISK FACTORS;

EID: 0029916982     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.1996.10718578     Document Type: Article

References (43)

1. Malinow MR: Hypcrhomocyst(e)inemia: a common and easily reversible risk factor for occlusive athcrosclcrosis. Circulation 81:2004-2006, 1990.
2. Ueland PM, Rcfsum H: Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Ub Clin Med 114:473-501, 1989.
3. Genest JJ Jr, McNamara JR. Salem DN, Wilson PWF, Schaefer EJ, Malinow MR: Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 16:1114-1119, 1990.
4. BratLstrtfm L, Lindgren A, Israelsson B, Malinow MR, Norrvmg B, Upson B, Hamfelt A: Hyperhomocysteinaemia in stroke: prevalence. cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 22:214-221, 1992.
5. Stampfer M, Malinow MR, Willett W, Newcomer L, Upson B, Ullmann D, Tishler P, Hcnnckcns C: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268:877-881, 1992.
6. Arnesen E, Refsum H, Bonaa KH. Ueland PM, Forde OH, Nor-drchaug JE: The Tromso Study: serum total homocysteine and myocardial infarction: a prospective study. (Abstract). Presented at the 3rd International Conference on Preventive Cardiology, June 27-July 1, 1993, Oslo, Norway.
7. Kang SS, Wong PWK, Norusis M: Homocystcincmia due to folate deficiency. Metabolism 36:458-462, 1987.
8. Andcrsson A, Brattstirim L, Israclsson B, Isaksson A, Hamfelt A, Hultberg B: Plasma homocystcinc before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 22:79-87, 1992.
9. Smolm LA. Crenshaw TD. Kurtycz J. Bcncvcnga NJ: Homocys-t(e)ine accumulation in pigs fed diets deficient in vitamin Bft: relationship to atherosclerosis. J Nutr 113:2022-2033, 1983.
10. Willett WC: Does low vitamin B-6 intake increase the risk of coronary heart disease? In Reynolds RD, Lcklem JE (eds): –Vitamin B-6: Its Role in Health and Disease.— New York: Alan R Liss, Inc. pp 337 346, 1985.
11. Ubbink JB, Vcrmaak WJ, van der Mcrwc A, Becker PJ: Vitamin B12, vitamin B-6. and folate nutritional status in men with hyper-homocystcincmia. Am J Clin Nutr 57:47-53, 1993.
12. Brattstrom LE, Israclsson B. Jeppson J-O, Hultberg BL: Folic acid-an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 48:215-221, 1988.
13. Selhub J, Jacques PF, Bostom AG. D'Agostino RB. Wilson PWF, Belanger AJ, O'Leary DH. Wolf PA, Schaefer EJ, Rosenberg IH: Association between plasma homocysteine concentrations and ex-tracranial carotid-artery stenosis. N Engl J Med 332:286 291, 1995.
14. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL. Rodney CPC, Alvarez JO. Macaluso M, Acton RT, Copeland RB. Cousins AL, Gore TB, Cornwell PE, Roseman JM: Plasma homocyst(c)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 59:940-948, 1994.
15. Brattstrom L, lsraelsson B, Norrving B. Bergqvist D, Thome J, Hultberg B. Hamfelt A: Impaired homocysteine metabolism in early-onsct cerebral and peripheral occlusive arterial disease: Effects of pyroxidine and folic acid treatment. Atherosclerosis 81: 51-60, 1990.
16. Subar AF, Block G, James I-D: Folate intake and food sources in the US population. Am J Clin Nutr 50:508-516, 1989.
17. Manorc MM, Vaughan LA, Carroll SS, Ixklcm JE: Plasma pyri-doxal 5' phosphate concentration and dietary vitamin B6 intake in free-living, low-income elderly people. Am J Clin Nutr 50:339-345, 1989.
18. –Assessment of the Folate Nutritional Status of the US Population Based on Data Collected in the Sccond National Health and Nutrition Examination Survey, 1976 1980.— Washington, DC: Food and Drug Administration, 1984.
19. Selhub J, Jacques PF. Wilson PWF. Rush D, Rosenberg IH: Vitamin status and intake as primary determinants of homocys-teinemia in an elderly population. JAMA 270:2693-2698, 1993.
20. Stampfer MJ, Bunng JE, Willett W, Rosncr B, Ebcrlcin K, Hcn-nekens CH: The 2X2 factorial design: its application to a randomized trial of aspirin and carotene in US physicians. Stat Med 4:111-116, 1985.
21. Steering Committee of the Physicians' Health Study Research Group: Final report on the aspirin component of ihe ongoing Physicians* Health Study. N Engl J Med 321:129-135, 1989.
22. IHD Registers: –Report of the Fifth Working Group.— Copenhagen, Denmark: World Health Organization, 1971.
23. Tamura T, Freeberg LE, Cornwell PE: Inhibition by EDTA of growth of Lactobacillus casei in the folate microbiological assay and its reversal by added manganese or iron. Clin Chcm 36:1993, 1990.
24. Camp VM, Chipponi J, Faraj BA: Radioenzymatic assay for direct measurement of plasma pyridoxal 5'-phosphate. Clin Chem 29: 642-644, 1983.
25. Smolin LA, Schneider JA: Measurement of total plasma cystcam-ine using high-pcrformancc liquid chromatography with electrochemical detection. Anal Biochem 168:374-379, 1988.
26. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B. Inahara T, Mukerjcc D, Sexton G, Upson BS: Prevalence of hyperhomo-cyst(c)inemia in patients with peripheral arterial occlusive disease. Circulation 79:1180-1188, 1989.
27. Malinow MR, Sexton G, Averbuch M, Grossman M, Wilson D, Upson B: Homocyst(c)inc in daily practicc: levels in coronary artery disease. Coronary Artery Dis 1:215-220, 1990.
28. Stampfcr MJ. Sacks FM, Salvini S, Willett WC, Hcnnekens CH: A prospective study of cholesterol, apolipoprotcins, and the risk of myocardial infarction. N Engl J Med 325:373-381, 1991.
29. Katrangi N, Kaplan LA, Stein EA: Separation and quantitation of 0-carotene and other carotenoids by high performance liquid chromatography. J Lipid Res 25:400-406, 1984.
30. Storer BE, Wacholder S, Breslow NE: Maximum likelihood fitting of general risk models to stratified data. Appl Stat 32:172-181, 1983.
31. Lcvenson J, Malinow MR, Girai PH. Razavian M, Simon A: Increased homocyst(e)ine levels in human hypertension. (Abstract). J Hypert 12:S74, 1994.
32. Rosenberg IH: Homocysteine, folic acid, and the prevention of vascular disease. Nutr Reviews 47:247-249, 1989.
33. Shultz TD, Leklem JE: Urinary 4-pyridoxic acid, urinary vitamin B-6 and plasma pyridoxal phosphate as measures of vitamin B-6 status and dietary intake in adults. In Leklem JE, Reynolds RD (eds): –Methods in Vitamin B-6 Nutrition.— New York: Plenum Press, pp 297-320, 1980.
34. Israelsson B, BrattstrOm L, Refsum H: Homocysteine in frozen plasma samples. A short cut to establish hyperhomocysteinaemia as a risk factor for arteriosclerosis? Scand J Clin Lab Invest 53:465-469, 1993.
35. Genest JJ Jr, McNamara JR, Upson B, Salem DN, Ordovas JM, Schaefer EJ, Malinow MR: Prevalence of familial hyperhomocys-t(e)incmia in men with premature coronary artery disease. Arterio Throm 11:1129-1136, 1991.
36. Williams RR, Malinow MR, Hunt SC, Upson B, Wu LL, Hopkins PN, Stults BN. Kuida H: Hypcrhomocyst(e)incmia in Utah siblings with early coronary disease. Coronary Artery Dis 1:681-685, 1990.
37. Reed T. Malinow MR, Christian JC, Upson B: Estimates of heri-tability for plasma homocyst(e)ine levels in aging adult male twins. Clin Genet 39:425-428, 1991.
38. Rubba P, Faccenda F, Pauciullo P, Carbone L, Mancini M, Stri-sciuglio P, Carrozza R, San orio R, del Giudice E, Andria G: Early signs of vascular disease in homocystinuria: a noninvasivc study by ultrasound methods in eight families with cystathioninc-bcta synthase deficiency. Metabolism 39:1191-1195, 1990.
39. Selhub J, Miller JW: The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylaiion and transsulfuration of homocysteine. Am J Clin Nutr 55:131-138, 1992.
40. Kang SS. Wong PWK, Susmano A. Sora J. Norusis M, Ruggic N: Thermolabile methylcnetctrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48:536-545, 1991.
41. Stabler SP, Marcell PD. Podli ER, Allen RH, Savage DG, Lin-denbaum J: Elevation of total homocysteine in the senim of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectromctry. J Clin Invest 81:466-474, 1988.
42. Brattstrom L, Israclsson B, Lindgiirdc F, Hultberg B: Higher total plasma homocysteine in vitamin B,2 deficiency than in heterozy gosity for homocystinuria due to cystathioninc 0-synthase deficiency. Metabolism 37:175-178, 1988.
43. Mudd SH, Irevy HL, Skovby F: Disorders of transulfuration. In Scrivcr CS, Beaudet AL, Sly WL, Valle D (eds): –The Metabolic Basis of Inherited Disease,— 6th ed. New York: McGraw-Hill International Book Co, pp 693-734, 1989.